{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:07:14Z","timestamp":1789063634994,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T00:00:00Z","timestamp":1783814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T00:00:00Z","timestamp":1783814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006254","name":"Ruhr-Universit\u00e4t Bochum","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006254","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Geriatr Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>A comprehensive geriatric assessment (CGA) followed by geriatric assessment-guided interventions was demonstrated to reduce treatment-related toxicities CTCAE III\u00b0\u2013V\u00b0 in older adults with cancer undergoing systemic cancer treatments, but implementation remains insufficient. Thus, we aimed to evaluate the feasibility of implementing CGA into routine care and multidisciplinary tumor boards (MDTs) in Germany within a bicentric feasibility trial (DRKS00035569; 19.12.2024).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients\u2009\u2265\u200965\u00a0years with positive geriatric screening (G8\u2009&lt;\u200915 points) and all patients\u2009\u2265\u200970\u00a0years received CGA as part of their routine care. Results were presented during MDT discussions to derive treatment recommendations. After CGA, patients were asked for trial participation which included data analysis and a telephone follow-up after 3\u00a0months. Clinicians participating in the MDT were asked about the added value of CGA presentation. Primary endpoint was the estimation of patient\u2019s willingness to participate with an accuracy of\u2009\u00b1\u20097.5% to inform design for a later (cost) effectiveness trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>75 patients received CGA (62.5% females). Of those, 72 (96%) agreed to participate (95% confidence interval, [0.8875; 0.9917]). With an accuracy of estimating the willingness to participate of\u2009&lt; |7.5%|, the primary endpoint was reached. The median age was 76.7\u00a0years (range 69\u201392\u00a0years). A member of the geriatric team attended 2\/3 of MDT meetings. Clinicians rated the integration of CGA results predominantly as useful.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Integration of CGA into routine care of older cancer patients is feasible but will likely require adequate geriatric staffing per center. A larger implementation study, evaluating efficacy and cost-effectiveness in the German healthcare system, is necessary.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s41999-026-01542-7","type":"journal-article","created":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T13:07:09Z","timestamp":1783861629000},"page":"2337-2350","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integration of geriatric assessment-guided care plan modifications and interventions into clinical paths of older adults with cancer (GORILLA): a feasibility approach"],"prefix":"10.1007","volume":"17","author":[{"given":"Rea Sujin","family":"Mayland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merlin","family":"Deterding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo Maria","family":"Verri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Heublein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Flemm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Achilles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin T.","family":"Turki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Roghmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Akuamoa-Boateng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Halagiera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Baues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Flossdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuowei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Strumberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gero","family":"Lueg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Denkinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8518-3616","authenticated-orcid":false,"given":"Nina Rosa","family":"Neuendorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,12]]},"reference":[{"key":"1542_CR1","doi-asserted-by":"publisher","DOI":"10.70401\/acrt.2023.59","author":"NR Neuendorff","year":"2023","unstructured":"Neuendorff NR, Reinhardt HC, Christofyllakis K (2023) Is less always more? Emerging treatment concepts in geriatric hemato-oncology. Ageing Cancer Res Treat. https:\/\/doi.org\/10.70401\/acrt.2023.59","journal-title":"Ageing Cancer Res Treat"},{"key":"1542_CR2","doi-asserted-by":"publisher","first-page":"afac104","DOI":"10.1093\/ageing\/afac104","volume":"51","author":"N Veronese","year":"2022","unstructured":"Veronese N, Custodero C, Demurtas J, Smith L, Barbagallo M, Maggi S et al (2022) Comprehensive geriatric assessment in older people: an umbrella review of health outcomes. Age Ageing 51:afac104. https:\/\/doi.org\/10.1093\/ageing\/afac104","journal-title":"Age Ageing"},{"key":"1542_CR3","doi-asserted-by":"publisher","first-page":"e214158","DOI":"10.1001\/jamaoncol.2021.4158","volume":"7","author":"D Li","year":"2021","unstructured":"Li D, Sun C-L, Kim H, Soto-Perez-de-Celis E, Chung V, Koczywas M et al (2021) Geriatric assessment-driven intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial. JAMA Oncol 7:e214158. https:\/\/doi.org\/10.1001\/jamaoncol.2021.4158","journal-title":"JAMA Oncol"},{"key":"1542_CR4","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/S0140-6736(21)01789-X","volume":"398","author":"SG Mohile","year":"2021","unstructured":"Mohile SG, Mohamed MR, Xu H, Culakova E, Loh KP, Magnuson A et al (2021) Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study. Lancet 398:1894\u20131904. https:\/\/doi.org\/10.1016\/S0140-6736(21)01789-X","journal-title":"Lancet"},{"key":"1542_CR5","doi-asserted-by":"publisher","first-page":"e617","DOI":"10.1016\/S2666-7568(22)00169-6","volume":"3","author":"WK Soo","year":"2022","unstructured":"Soo WK, King MT, Pope A, Parente P, D\u0101rzi\u0146\u0161 P, Davis ID (2022) Integrated geriatric assessment and treatment effectiveness (INTEGERATE) in older people with cancer starting systemic anticancer treatment in Australia: a multicentre, open-label, randomised controlled trial. Lancet Healthy Longev 3:e617\u2013e627. https:\/\/doi.org\/10.1016\/S2666-7568(22)00169-6","journal-title":"Lancet Healthy Longev"},{"key":"1542_CR6","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1038\/s41416-021-01367-0","volume":"124","author":"CM Lund","year":"2021","unstructured":"Lund CM, Vistisen KK, Olsen AP, Bardal P, Schultz M, Dolin TG et al (2021) The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO). Br J Cancer 124:1949\u20131958. https:\/\/doi.org\/10.1038\/s41416-021-01367-0","journal-title":"Br J Cancer"},{"key":"1542_CR7","doi-asserted-by":"publisher","first-page":"101585","DOI":"10.1016\/j.jgo.2023.101585","volume":"14","author":"D Disalvo","year":"2023","unstructured":"Disalvo D, Moth E, Soo WK, Garcia MV, Blinman P, Steer C et al (2023) The effect of comprehensive geriatric assessment on care received, treatment completion, toxicity, cancer-related and geriatric assessment outcomes, and quality of life for older adults receiving systemic anti-cancer treatment: a systematic review. J Geriatr Oncol 14:101585. https:\/\/doi.org\/10.1016\/j.jgo.2023.101585","journal-title":"J Geriatr Oncol"},{"key":"1542_CR8","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1200\/JCO.2018.78.8687","volume":"36","author":"SG Mohile","year":"2018","unstructured":"Mohile SG, Dale W, Somerfield MR, Schonberg MA, Boyd CM, Burhenn PS et al (2018) Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology. J Clin Oncol 36:2326\u20132347. https:\/\/doi.org\/10.1200\/JCO.2018.78.8687","journal-title":"J Clin Oncol"},{"key":"1542_CR9","doi-asserted-by":"publisher","first-page":"103657","DOI":"10.1016\/j.esmoop.2024.103657","volume":"9","author":"KP Loh","year":"2024","unstructured":"Loh KP, Liposits G, Arora SP, Neuendorff NR, Gomes F, Krok-Schoen JL et al (2024) Adequate assessment yields appropriate care\u2014the role of geriatric assessment and management in older adults with cancer: a position paper from the ESMO\/SIOG cancer in the elderly working group. ESMO Open 9:103657. https:\/\/doi.org\/10.1016\/j.esmoop.2024.103657","journal-title":"ESMO Open"},{"key":"1542_CR10","unstructured":"Deutsche Gesellschaft f\u00fcr Geriatrie e.V. (DGG) (2024) S3-Leitlinie \u201eUmfassendes Geriatrisches Assessment (Comprehensive Geriatric Assessment, CGA) bei hospitalisierten Patientinnen und Patienten\u201c. AWMF-Register 2024; Langversion 1.1; https:\/\/register.awmf.org\/assets\/guidelines\/084-003l_S3_Umfassendes-Geriatrisches-Assessment-Comprehensive-Geriatric-Assessment-CGA-bei-hospitalisierten-PatientInnen_2024-06.pdf"},{"key":"1542_CR11","doi-asserted-by":"publisher","first-page":"102078","DOI":"10.1016\/j.jgo.2024.102078","volume":"16","author":"M H\u00fcttmeyer","year":"2025","unstructured":"H\u00fcttmeyer M, Tatschner K, Jentschke E, Roch C, Deschler-Baier B (2025) Increasing the evidence for comprehensive geriatric assessment\u2014outlook on another work in progress. J Geriatr Oncol 16:102078. https:\/\/doi.org\/10.1016\/j.jgo.2024.102078","journal-title":"J Geriatr Oncol"},{"key":"1542_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000529097","volume":"46","author":"MK Stahl","year":"2023","unstructured":"Stahl MK, Ertl SW, Engelmeyer P, Heuer H-C, Christoph DC (2023) Impact of geriatric assessment on the tolerability of combination chemotherapy in older patients with advanced cancer: a matched-pair analysis. Oncol Res Treat 46:100\u2013105. https:\/\/doi.org\/10.1159\/000529097","journal-title":"Oncol Res Treat"},{"key":"1542_CR13","unstructured":"Mayland RS, Verri FM, Deterding M, Heublein S, Aslan A, Turki AT et al Integration of geriatric assessment\u2014guided care plan modifications and interventions into clinical paths of older adults with cancer (GORILLA): study protocol of a prospective cohort trial n.d."},{"key":"1542_CR14","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/jgs.18124","volume":"71","author":"JS Fasnacht","year":"2023","unstructured":"Fasnacht JS, Wueest AS, Berres M, Thomann AE, Krumm S, Gutbrod K et al (2023) Conversion between the Montreal cognitive assessment and the Mini\u2010Mental status examination. J Am Geriatr Soc 71:869\u2013879. https:\/\/doi.org\/10.1111\/jgs.18124","journal-title":"J Am Geriatr Soc"},{"key":"1542_CR15","first-page":"61","volume":"14","author":"FI Mahoney","year":"1965","unstructured":"Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel Index. Md State Med J 14:61\u201365","journal-title":"Md State Med J"},{"key":"1542_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","volume":"9","author":"MP Lawton","year":"1969","unstructured":"Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9:179\u2013186. https:\/\/doi.org\/10.1093\/geront\/9.3_Part_1.179","journal-title":"Gerontologist"},{"key":"1542_CR17","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jamda.2013.05.018","volume":"14","author":"TK Malmstrom","year":"2013","unstructured":"Malmstrom TK, Morley JE (2013) SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc 14:531\u2013532. https:\/\/doi.org\/10.1016\/j.jamda.2013.05.018","journal-title":"J Am Med Dir Assoc"},{"key":"1542_CR18","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jamda.2019.12.011","volume":"21","author":"M Drey","year":"2020","unstructured":"Drey M, Ferrari U, Schraml M, Kemmler W, Schoene D, Franke A et al (2020) German version of SARC-F: translation, adaption, and validation. J Am Med Dir Assoc 21:747\u2013751.e1. https:\/\/doi.org\/10.1016\/j.jamda.2019.12.011","journal-title":"J Am Med Dir Assoc"},{"key":"1542_CR19","doi-asserted-by":"publisher","first-page":"M85","DOI":"10.1093\/geronj\/49.2.M85","volume":"49","author":"JM Guralnik","year":"1994","unstructured":"Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG et al (1994) A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 49:M85\u2013M94. https:\/\/doi.org\/10.1093\/geronj\/49.2.M85","journal-title":"J Gerontol"},{"key":"1542_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"key":"1542_CR21","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1200\/OP.23.00263","volume":"19","author":"GR Williams","year":"2023","unstructured":"Williams GR, Hopkins JO, Klepin HD, Lowenstein LM, Mackenzie A, Mohile SG et al (2023) Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline questions and answers. JCO Oncol Pract 19:718\u2013723. https:\/\/doi.org\/10.1200\/OP.23.00263","journal-title":"JCO Oncol Pract"},{"key":"1542_CR22","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3233\/JAD-180080","volume":"64","author":"AE Thomann","year":"2018","unstructured":"Thomann AE, Goettel N, Monsch RJ, Berres M, Jahn T, Steiner LA et al (2018) The Montreal cognitive assessment: normative data from a German-speaking cohort and comparison with international normative samples. JAD 64:643\u2013655. https:\/\/doi.org\/10.3233\/JAD-180080","journal-title":"JAD"},{"key":"1542_CR23","unstructured":"Interdisziplin\u00e4rer Arbeitskreis Geriatrische Onkologie der DGHO, DGG, AIO (2023) Practical Geriatric Assessment (PGA)\u2014Assessment und Management (Deutschsprachige Version nach Dale et al. 2023); https:\/\/www.dgho.de\/arbeitskreise\/a-g\/geriatrische-onkologie\/dokumente-des-ak\/pga-assessment-management-deutschsprachige-version.pdf"},{"key":"1542_CR24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00391-009-0067-z","volume":"43","author":"S Heidenblut","year":"2010","unstructured":"Heidenblut S, Zank S (2010) Entwicklung eines neuen Depressionsscreenings f\u00fcr den Einsatz in der Geriatrie: Die \u201eDepression-im-Alter-Skala\u201c (DIA-S). Z Gerontol Geriat 43:170\u2013176. https:\/\/doi.org\/10.1007\/s00391-009-0067-z","journal-title":"Z Gerontol Geriat"},{"key":"1542_CR25","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1200\/JCO.2008.19.9463","volume":"27","author":"A Hurria","year":"2009","unstructured":"Hurria A, Li D, Hansen K, Patil S, Gupta R, Nelson C et al (2009) Distress in older patients with cancer. JCO 27:4346\u20134351. https:\/\/doi.org\/10.1200\/JCO.2008.19.9463","journal-title":"JCO"},{"key":"1542_CR26","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/cmaj.050051","volume":"173","author":"K Rockwood","year":"2005","unstructured":"Rockwood K (2005) A global clinical measure of fitness and frailty in elderly people. Can Med Assoc J 173:489\u2013495. https:\/\/doi.org\/10.1503\/cmaj.050051","journal-title":"Can Med Assoc J"},{"key":"1542_CR27","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1007\/s12603-009-0214-7","volume":"13","author":"MJ Kaiser","year":"2009","unstructured":"Kaiser MJ, Bauer JM, Ramsch C, Uter W, Guigoz Y, Cederholm T et al (2009) Validation of the Mini Nutritional Assessment short-form (MNA\u00ae-SF): a practical tool for identification of nutritional status. J Nutr Health Aging 13:782\u2013788. https:\/\/doi.org\/10.1007\/s12603-009-0214-7","journal-title":"J Nutr Health Aging"},{"key":"1542_CR28","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1111\/j.1532-5415.2011.03659.x","volume":"59","author":"MJ Kaiser","year":"2011","unstructured":"Kaiser MJ, Bauer JM, Uter W, Donini LM, Stange I, Volkert D et al (2011) Prospective validation of the modified mini nutritional assessment short\u2010forms in the community, nursing home, and rehabilitation setting. J Am Geriatr Soc 59:2124\u20132128. https:\/\/doi.org\/10.1111\/j.1532-5415.2011.03659.x","journal-title":"J Am Geriatr Soc"},{"key":"1542_CR29","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, Charbonneau S, Whitehead V, Collin I et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695\u2013699. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x","journal-title":"J Am Geriatr Soc"},{"key":"1542_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1017\/S1041610297004754","volume":"9","author":"D William Molloy","year":"1997","unstructured":"William Molloy D, Standish TIM (1997) A guide to the standardized Mini-Mental State Examination. Int Psychogeriatr 9:87\u201394. https:\/\/doi.org\/10.1017\/S1041610297004754","journal-title":"Int Psychogeriatr"},{"key":"1542_CR31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/gps.585","volume":"17","author":"U Schramm","year":"2002","unstructured":"Schramm U, Berger G, M\u00fcller R, Kratzsch T, Peters J, Fr\u00f6lich L (2002) Psychometric properties of Clock Drawing Test and MMSE or Short Performance Test (SKT) in dementia screening in a memory clinic population. Int J Geriatr Psychiatry 17:254\u2013260. https:\/\/doi.org\/10.1002\/gps.585","journal-title":"Int J Geriatr Psychiatry"},{"key":"1542_CR32","doi-asserted-by":"publisher","first-page":"101703","DOI":"10.1016\/j.jgo.2024.101703","volume":"15","author":"MH Habib","year":"2024","unstructured":"Habib MH, Alibhai SMH, Puts M (2024) How representative are participants in geriatric oncology clinical trials? The case of the 5C RCT in geriatric oncology: a cross-sectional comparison to a geriatric oncology clinic. J Geriatr Oncol 15:101703. https:\/\/doi.org\/10.1016\/j.jgo.2024.101703","journal-title":"J Geriatr Oncol"},{"key":"1542_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-531-90665-2","volume-title":"Qualitative Datenanalyse: computergest\u00fctzt: Methodische Hintergr\u00fcnde und Beispiele aus der Forschungspraxis","year":"2007","unstructured":"Kuckartz U, Dresing T, Grunenberg H (eds) (2007) Qualitative Datenanalyse: computergest\u00fctzt: Methodische Hintergr\u00fcnde und Beispiele aus der Forschungspraxis, 2., \u00fcberarbeitete und erweiterte Auflage. VS Verlag f\u00fcr Sozialwissenschaften, Wiesbaden. https:\/\/doi.org\/10.1007\/978-3-531-90665-2","edition":"2., \u00fcberarbeite"},{"key":"1542_CR34","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/jnci\/djab070","volume":"113","author":"D Habr","year":"2021","unstructured":"Habr D, McRoy L, Papadimitrakopoulou VA (2021) Age is just a number: considerations for older adults in cancer clinical trials. JNCI J Natl Cancer Inst 113:1460\u20131464. https:\/\/doi.org\/10.1093\/jnci\/djab070","journal-title":"JNCI J Natl Cancer Inst"},{"key":"1542_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12910-025-01255-9","volume":"26","author":"C DuMontier","year":"2025","unstructured":"DuMontier C, Dale W, Revette AC, Roberts J, Sanyal A, Perumal N et al (2025) Ethics of overtreatment and undertreatment in older adults with cancer. BMC Med Ethics 26:105. https:\/\/doi.org\/10.1186\/s12910-025-01255-9","journal-title":"BMC Med Ethics"},{"key":"1542_CR36","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jgo.2022.04.008","volume":"13","author":"M Hamaker","year":"2022","unstructured":"Hamaker M, Lund C, Te Molder M, Soubeyran P, Wildiers H, Van Huis L et al (2022) Geriatric assessment in the management of older patients with cancer\u2014a systematic review (update). J Geriatr Oncol 13:761\u2013777. https:\/\/doi.org\/10.1016\/j.jgo.2022.04.008","journal-title":"J Geriatr Oncol"},{"key":"1542_CR37","doi-asserted-by":"publisher","first-page":"102433","DOI":"10.1016\/j.jgo.2025.102433","volume":"16","author":"T Lamy","year":"2025","unstructured":"Lamy T, Pages A, Thomas ZA, Chaulet GB, Iacob M, Bintein F et al (2025) Impact of a dedicated geriatric oncology tumor-board on therapeutic decision-making in patients aged 70 and over with cancer: the OncoBoardAge study. J Geriatr Oncol 16:102433. https:\/\/doi.org\/10.1016\/j.jgo.2025.102433","journal-title":"J Geriatr Oncol"},{"key":"1542_CR38","doi-asserted-by":"publisher","first-page":"e056147","DOI":"10.1136\/bmjopen-2021-056147","volume":"12","author":"AB Coulson","year":"2022","unstructured":"Coulson AB, Royle K-L, Pawlyn C, Cairns DA, Hockaday A, Bird J et al (2022) Frailty-adjusted therapy in transplant non-eligible patients with newly diagnosed multiple myeloma (FiTNEss (UK-MRA myeloma XIV trial)): a study protocol for a randomised phase III trial. BMJ Open 12:e056147. https:\/\/doi.org\/10.1136\/bmjopen-2021-056147","journal-title":"BMJ Open"},{"key":"1542_CR39","doi-asserted-by":"publisher","first-page":"102339","DOI":"10.1016\/j.jgo.2025.102339","volume":"16","author":"G Liposits","year":"2025","unstructured":"Liposits G, Baxter MA, Brown-Kerr A, O\u2019Hanlon S (2025) Personalized palliative care for older adults with cancer: a call for action on oncogeriatric palliative care. J Geriatr Oncol 16:102339. https:\/\/doi.org\/10.1016\/j.jgo.2025.102339","journal-title":"J Geriatr Oncol"},{"key":"1542_CR40","doi-asserted-by":"publisher","first-page":"100743","DOI":"10.1016\/j.lanhl.2025.100743","volume":"6","author":"C Kenis","year":"2025","unstructured":"Kenis C, Peeters L, Laethem L, De Cock J, Compt\u00e9 N, Flamaing J et al (2025) Effectiveness of comprehensive geriatric assessment with extensive patient coaching for improving quality of life in older patients with solid tumours receiving systemic therapy (G-oncoCOACH): a multicentre randomised controlled trial. Lancet Healthy Longev 6:100743. https:\/\/doi.org\/10.1016\/j.lanhl.2025.100743","journal-title":"Lancet Healthy Longev"},{"key":"1542_CR41","doi-asserted-by":"publisher","first-page":"1570889","DOI":"10.3389\/fonc.2025.1570889","volume":"15","author":"SP Hiltgen","year":"2025","unstructured":"Hiltgen SP, Bischoff-Ferrari HA, Gagesch M, Kaltenborn A, Manz MG, Rieger MJ et al (2025) Implementing comprehensive geriatric assessment in an academic hematologic outpatient setting: experiences from medical doctors and patients. Front Oncol 15:1570889. https:\/\/doi.org\/10.3389\/fonc.2025.1570889","journal-title":"Front Oncol"}],"container-title":["European Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-026-01542-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41999-026-01542-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-026-01542-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:24:20Z","timestamp":1789061060000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41999-026-01542-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,12]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1542"],"URL":"https:\/\/doi.org\/10.1007\/s41999-026-01542-7","relation":{},"ISSN":["1878-7657"],"issn-type":[{"value":"1878-7657","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,12]]},"assertion":[{"value":"14 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"NRN has received honoraria and travel support by Janssen-Cilag, Medac, Novartis, Pfizer, Abbvie, and Jazz Pharmaceutical. RW has received honoraria and travel support from Novartis, Nutricia, Heel, and InfectoPharm. ATT has received research funding by Neovii Biotech;\u00a0\u00a0 consultancy for CSL Behring, Maat Pharma, Biomarin, Pfizer, and Onkowissen, and\u00a0 travel reimbursements by Neovii and Novartis. MD has received honoraria from Pfizer, Boehringer-Ingelheim, Daiichi-Sankyo, Amgen, and Astra-Zeneca which was not related to oncology. All other authors declare no conflicts of interest (RSM, MD, FMV, SH, AA, CG, FR, PH, CB, SF, NW, DS, G, JA, and DAB).","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of the University of Ulm on October 30, 2024 (351\/24\u2013FSt\/Sta), and by the IRB of Westphalia-Lippe on January 23, 2025 (2024-700-f-S). The study is registered at the German Clinical Trials Register (Deutsches Register f\u00fcr klinische Studien, DRKS), DRKS00035569.","order":2,"name":"Ethics","label":"Institutional review board statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all participants involved in the study.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}